Episode description
In this episode, we discuss Nvidia's strategic move to invest $50 million into Recursion, a company at the forefront of AI-enabled drug discovery. We examine how Nvidia's technology and Recursion's AI expertise could revolutionize the pharma industry.
Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: https://AIBox.ai/